𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intrapleural streptokinase for recurrent multiloculated malignant pleural effusions (MMPE)

✍ Scribed by A.M. Alizzi; L.A. Sposato; J.M. Hemli; A.H. Al-Masri; M.M. Murton; A.S. Dixit; M. Windsor; K. Matar; D.C. McKenzie

Book ID
119255985
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
48 KB
Volume
18
Category
Article
ISSN
1443-9506

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intrapleural mitoxantrone for the pallia
Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions
✍ Manuel Morales; Maria del Carmen ExpΓ³sito πŸ“‚ Article πŸ“… 1995 πŸ› Springer-Verlag 🌐 English βš– 230 KB

A group of 21 patients with malignant pleural effusions were treated with the instillation of 40 mg mitoxantrone intrapleurally, after complete fluid drainage. There was a 100% complete response rate with no toxic effects (0%). The mean survival of the patients was 57.1 weeks.

Intrapleural talc for the treatment of m
Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer
✍ Ribas C. Milanez; Francisco S. Vargas; Luiz B. Filomeno; Lisete R. Teixeira; Ang πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 448 KB πŸ‘ 2 views

Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi